İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Makale detayı · 2021 · article

Topological network mechanisms of clinical response to antidepressant treatment in drug-naive major depressive disorder

Dergi Journal of Clinical Neuroscience
ISSN0967-5868
YÖKSİS OpenAlex Açık erişim · green
Yıl2021
Atıf4OpenAlex
Atıf3Semantic Scholar
Yüzdelik%48,8
FWCI0,21,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q4
DOI10.1016/j.jocn.2020.12.001 OpenAlexOpenAlex kaydı

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıJournal of Clinical Neuroscience
  • Katalog eşleşmesi (ISSN)Journal of Clinical Neuroscience
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

4atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 7 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trialAtıf 5 · OpenAlex
  2. 2025 Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trialAtıf 5 · OpenAlex
  3. 2025 Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trialAtıf 5 · OpenAlex
  4. 2025 Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trialAtıf 5 · OpenAlex
  5. 2025 Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trialAtıf 5 · OpenAlex
  6. 2025 Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trialAtıf 5 · OpenAlex
  7. 2024 Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trialAtıf 5 · OpenAlex

Yazarlar

12
  1. ABDULLAH BURAK UYGUR 1
  2. SULTAN YILDIZ 2
  3. HALİL AZİZ VELİOĞLU 3
  4. AHMET ÖZŞİMŞEK ALANYA ALAADDİN KEYKUBAT ÜNİVERSİTESİ 4
  5. ECE ÖZDEMŞR ÖKTEN 5
  6. ZÜBEYİR BAYRAKTAROĞLU 6
  7. TARKAN ERGÜN 7
  8. HATİCE LAKADAMYALI ALANYA ALAADDİN KEYKUBAT ÜNİVERSİTESİ 8
  9. LÜTFÜ HANOĞLU İSTANBUL MEDİPOL ÜNİVERSİTESİ 9
  10. ŞEYDA ÇANKAYA ALANYA ALAADDİN KEYKUBAT ÜNİVERSİTESİ 10
  11. ÖZLEM SAATCİ 11
  12. BURAK YULUĞ ALANYA ALAADDİN KEYKUBAT ÜNİVERSİTESİ 12